CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU) today announced that it has commenced an underwritten public offering of approximately $50 million of shares of its common stock. The number of shares to be offered and the price per share for the proposed offering have not yet been determined. All of the shares in the offering are to be sold by Cerulean.
Help employers find you! Check out all the jobs and post your resume.